DK3288577T3 - Adiponectin-peptidomimetika til behandling af øjenlidelser - Google Patents
Adiponectin-peptidomimetika til behandling af øjenlidelser Download PDFInfo
- Publication number
- DK3288577T3 DK3288577T3 DK16789840.2T DK16789840T DK3288577T3 DK 3288577 T3 DK3288577 T3 DK 3288577T3 DK 16789840 T DK16789840 T DK 16789840T DK 3288577 T3 DK3288577 T3 DK 3288577T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- eye disorders
- adiponectin peptidomimetics
- adiponectin
- peptidomimetics
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562156127P | 2015-05-01 | 2015-05-01 | |
| PCT/US2016/030142 WO2016179007A1 (en) | 2015-05-01 | 2016-04-29 | Adiponectin peptidomimetics for treating ocular disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3288577T3 true DK3288577T3 (da) | 2022-01-10 |
Family
ID=57218292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16789840.2T DK3288577T3 (da) | 2015-05-01 | 2016-04-29 | Adiponectin-peptidomimetika til behandling af øjenlidelser |
Country Status (13)
| Country | Link |
|---|---|
| US (6) | US10987401B2 (da) |
| EP (3) | EP4014985A1 (da) |
| JP (1) | JP7245649B2 (da) |
| KR (2) | KR20170141692A (da) |
| CN (3) | CN107530396B (da) |
| AU (3) | AU2016257724B2 (da) |
| CA (3) | CA3191203A1 (da) |
| DK (1) | DK3288577T3 (da) |
| ES (1) | ES2903448T3 (da) |
| HK (1) | HK1246178A1 (da) |
| IL (1) | IL272449A (da) |
| SG (1) | SG11202001140UA (da) |
| WO (2) | WO2016179007A1 (da) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4014985A1 (en) | 2015-05-01 | 2022-06-22 | Allysta Pharmaceuticals, Inc. | Adiponectin peptidomimetics for treating ocular disorders |
| SG11201907579VA (en) * | 2017-03-09 | 2019-09-27 | Allysta Pharmaceuticals Inc | Peptides for dry eye disease |
| CN107149676A (zh) * | 2017-05-05 | 2017-09-12 | 杨硕 | 脂联素和脂联素/胰岛素混合液在改善及治疗眼表角膜上皮及神经损伤中的应用 |
| WO2019061491A1 (en) * | 2017-09-30 | 2019-04-04 | Pro Sunfun Biotech Research And Development Co., Ltd. | PEPTIDE FOR OCULAR CARE, COMPOSITION AND METHOD OF USE THEREOF |
| CN109912685B (zh) * | 2017-12-13 | 2022-05-06 | 三凡生技研发股份有限公司 | 眼睛保护胜肽及其组合物及使用该胜肽的用途 |
| CA3095073A1 (en) * | 2018-03-23 | 2019-09-26 | Arch Biosurgery, Inc. | Sap and peptidomimetics for treatment of eye disease |
| CA3116065A1 (en) * | 2018-10-24 | 2020-04-30 | Allysta Pharmaceuticals, Inc. | Adiponectin peptidomimetics formulations |
| US11229549B2 (en) * | 2019-09-18 | 2022-01-25 | Vance M. Thompson | Tear transplantation and multi-part contact lens with absorbent portion |
| US11931454B2 (en) | 2019-09-18 | 2024-03-19 | Alcon Inc. | Wet-packed soft hydrogel ocular inserts |
| US11213551B1 (en) | 2021-04-05 | 2022-01-04 | Korb Research, Llc. | Ocular treatment compositions and methods of use thereof |
| CA3234071A1 (en) * | 2021-10-20 | 2023-04-27 | Stealth Biotherapeutics Inc. | Methods and compositions comprising peptidomimitics for treating, preventing, inhibiting, ameliorating or delaying the onset of ophthalmic conditions |
| WO2023069255A1 (en) * | 2021-10-20 | 2023-04-27 | Stealth Biotherapeutics Inc. | Methods and compositions comprising peptidomimitics for treating, preventing, inhibiting, ameliorating or delaying the onset of ophthalmic conditions |
| WO2023107796A1 (en) * | 2021-12-11 | 2023-06-15 | The Regents Of The University Of California | Ophthalmic formulations for macular degeneration |
| KR102609115B1 (ko) * | 2023-06-08 | 2023-12-05 | 주식회사 엔큐라젠 | 펩타이드를 포함하는 안구 질환의 치료용 조성물 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5108921A (en) | 1989-04-03 | 1992-04-28 | Purdue Research Foundation | Method for enhanced transmembrane transport of exogenous molecules |
| US5643575A (en) | 1993-10-27 | 1997-07-01 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
| US5824784A (en) | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
| DE4437604A1 (de) | 1994-10-21 | 1996-04-25 | Basf Ag | Konjugate aus einem Poly- oder Oligopeptid und einer niedermolekularen lipophilen Verbindung |
| US5932462A (en) | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
| CA2330451A1 (en) | 1998-04-28 | 1999-11-04 | Applied Research Systems Ars Holding N.V. | Polyol-ifn-beta conjugates |
| GB9814527D0 (en) | 1998-07-03 | 1998-09-02 | Cyclacel Ltd | Delivery system |
| CA2473781A1 (en) | 2002-01-18 | 2003-07-31 | Protemix Corporation Limited | Glycoisoforms of adiponectin and uses thereof |
| EA200900786A1 (ru) * | 2005-04-29 | 2009-10-30 | Зе Риджентс Оф Зи Юнивесити Оф Кэлифонье | Пептид в качестве лекарственного средства и способ лечения патологий, связанных с воспалительными процессами, посредством пептида |
| US9073965B2 (en) * | 2011-04-12 | 2015-07-07 | Temple University—Of the Commonwealth System of Higher Education | Adiponectin receptor agonists and methods of use |
| KR101438744B1 (ko) | 2012-08-02 | 2014-09-15 | 전남대학교산학협력단 | 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물 |
| PT2911623T (pt) * | 2012-10-26 | 2019-11-21 | Forsight Vision5 Inc | Sistema oftálmico para libertação prolongada de fármaco no olho |
| EP4014985A1 (en) * | 2015-05-01 | 2022-06-22 | Allysta Pharmaceuticals, Inc. | Adiponectin peptidomimetics for treating ocular disorders |
-
2016
- 2016-04-29 EP EP21204663.5A patent/EP4014985A1/en not_active Withdrawn
- 2016-04-29 CA CA3191203A patent/CA3191203A1/en active Pending
- 2016-04-29 EP EP16789840.2A patent/EP3288577B1/en active Active
- 2016-04-29 AU AU2016257724A patent/AU2016257724B2/en active Active
- 2016-04-29 CN CN201680023972.XA patent/CN107530396B/zh active Active
- 2016-04-29 DK DK16789840.2T patent/DK3288577T3/da active
- 2016-04-29 KR KR1020177031104A patent/KR20170141692A/ko not_active Application Discontinuation
- 2016-04-29 CA CA2981822A patent/CA2981822C/en active Active
- 2016-04-29 CN CN202210970186.8A patent/CN115919996A/zh active Pending
- 2016-04-29 WO PCT/US2016/030142 patent/WO2016179007A1/en active Application Filing
- 2016-04-29 ES ES16789840T patent/ES2903448T3/es active Active
- 2016-04-29 US US15/571,039 patent/US10987401B2/en active Active
- 2016-04-29 JP JP2018508628A patent/JP7245649B2/ja active Active
-
2017
- 2017-08-14 US US15/676,968 patent/US10537608B2/en active Active
-
2018
- 2018-05-03 HK HK18105714.4A patent/HK1246178A1/zh unknown
- 2018-08-07 SG SG11202001140UA patent/SG11202001140UA/en unknown
- 2018-08-07 CN CN201880052451.6A patent/CN111032070A/zh active Pending
- 2018-08-07 EP EP18845611.5A patent/EP3668530A4/en not_active Withdrawn
- 2018-08-07 CA CA3071670A patent/CA3071670A1/en active Pending
- 2018-08-07 AU AU2018318008A patent/AU2018318008A1/en not_active Abandoned
- 2018-08-07 KR KR1020207007015A patent/KR20200039749A/ko not_active Application Discontinuation
- 2018-08-07 WO PCT/US2018/045527 patent/WO2019036223A1/en unknown
-
2019
- 2019-11-24 US US16/693,355 patent/US11273197B2/en active Active
-
2020
- 2020-02-04 IL IL272449A patent/IL272449A/en unknown
-
2021
- 2021-01-11 US US17/146,397 patent/US11464825B2/en active Active
- 2021-05-20 AU AU2021203254A patent/AU2021203254A1/en active Pending
-
2022
- 2022-02-24 US US17/680,181 patent/US20220331393A1/en active Pending
- 2022-10-04 US US17/937,849 patent/US20230074446A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3570844T3 (da) | Azolopyrimidin til behandlingen af kræftrelaterede lidelser | |
| DK3288577T3 (da) | Adiponectin-peptidomimetika til behandling af øjenlidelser | |
| DK3261640T3 (da) | 5ht-agonister til behandling af epilepsilidelser | |
| DK3185876T3 (da) | Sammensætninger og fremgangsmåder til behandling af neurologiske lidelser | |
| DK3125875T3 (da) | Inhalerbar rapamycinformulering til behandling af aldersrelaterede tilstande | |
| DK3286311T3 (da) | Fremgangsmåde til behandling af maligniteter | |
| DK3119397T3 (da) | Heterocykliske forbindelser til anvendelse i behandling af PI3K-gamma-medierede lidelser | |
| DK3466432T3 (da) | Fremgangsmåder til behandling af pulmonale non-tuberkuløse mykobakterielle infektioner | |
| DK3362066T3 (da) | Kombinationsterapi til behandling af maligniteter | |
| DK3325443T3 (da) | Fremgangsmåde til fremstilling af pridopidin | |
| DK3240612T3 (da) | Fremgangsmåder til behandling af nethindesygdomme | |
| DK3481846T3 (da) | 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande | |
| DK3390390T3 (da) | Bipyrazolylderivater egnede til behandling af autoimmunsygdomme | |
| DK3524255T3 (da) | Sammensætning til behandling af acne | |
| DK3157534T3 (da) | Acetylcholinesterasehæmmere til behandling af dermatologiske tilstande | |
| DK3307267T3 (da) | Behandling af multipel sklerose | |
| DK3439661T3 (da) | Fremgangsmåder til behandling af øjenlidelser | |
| DK3280408T3 (da) | Fremgangsmåde til fremstilling af dicycloplatin | |
| DK3261661T3 (da) | Menotropin til behandling af infertilitet | |
| DK3430143T3 (da) | Inhibitorer af SRSF1 til behandlingen af neurodegenerative sygdomme | |
| DK3192524T3 (da) | Hgf præparat egnet til behandling af neurologiske lidelser | |
| DK3122349T3 (da) | Sammensætninger til behandling af autodigestion | |
| DK3724173T3 (da) | Forbindelser til behandling af neuromuskulære lidelser | |
| DK3209295T3 (da) | Fremgangsmåder til behandling af øjenlidelser | |
| DK3096775T3 (da) | SOCS-mimetika til behandling af sygdomme |